Study: Urgent care often prescribes inappropriate medications
Urgent care clinics are handing out fistfuls of antibiotics, steroids and opioids for conditions these drugs won't help, a new study says.
"Previous studies had shown that patients continue to receive antibiotics for diagnoses where they may not be indicated, such as for a viral respiratory infection, especially in urgent care settings," said co-lead researcher Dr. Shirley Cohen-Mekelburg, an assistant professor of internal medicine at the University of Michigan Medical School.
"Our findings reveal that this trend of inappropriate prescribing includes other classes of drugs -- including glucocorticoids -- and a variety of conditions," Cohen-Mekelburg added in a news release.
For the study, published Tuesday in the Annals of Internal Medicine, researchers analyzed health care data for more than 22.4 million urgent care visits that occurred between 2018 and 2022.
More than 12% of those visits resulted in a prescription for antibiotics, 9% in a steroid prescription and 1% in a scrip for opioids.
The research team then looked to see how many prescriptions were handed out for health conditions the drugs aren't meant to treat.
Among the inappropriate prescriptions, researchers found:
Antibiotics prescribed for more than 30% of patients with ear infections, nearly 46% of patients with urinary symptoms and 15% of patients with bronchitis.
Steroids prescribed for nearly 24% of patients with a sinus infection, 41% of patients with bronchitis and 12% of patients with upper respiratory infections.
Opioids prescribed for nearly 5% of patients with muscle pain, more than 6% of patients with abdominal pain or GI symptoms and 4% of patients with sprains or strains.
These results jibe with recent studies showing that urgent care is the most common type of health care visit to result in inappropriate prescriptions for antibiotics to treat viral respiratory infections, researchers said.
The drugs are likely being handed out because the urgent care staff doesn't know better, patients are demanding specific meds and no one is providing back-up support for decisions about prescribing, researchers said.
The consequences may be far-reaching: Antibiotic-resistant bacteria like MRSA have become a growing threat to health, due to the overuse of antibiotics.
Likewise, America's opioid crisis has been fueled by too many painkiller prescriptions doled out for dicey reasons.
Researchers concluded that drug stewardship programs are needed to make sure urgent care clinics are handing out the right drugs for the right conditions.
"Reducing inappropriate prescribing of antibiotics, glucocorticoids and opioids will require a multifaceted approach," Cohen-Mekelburg said. "Providers at urgent centers would benefit from greater support and feedback in making these decisions."
More information
The Mayo Clinic has more on urgent care.
Copyright © 2025 HealthDay. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
3 hours ago
- UPI
Rise in colon cancer cases attributed to lower screening age
The American Cancer Society says an uptick in colon cancer cases in the 45-49 age group is a result of lowered screening ages leading to earlier detection. Photo by Adobe Stock/HealthDay There's been a steep increase in colon cancer cases among adults 45 to 49 in recent years, and that's a good thing, experts say. This upsurge means that more colon cancers are being caught at an earlier, more treatable stage, thanks to a decision to lower the screening age from 50 to 45, researchers argue in a pair of new studies from the American Cancer Society. "It is promising news because the uptick of cases is likely due to first-time screening in the wake of new recommendations for younger average-risk adults to begin testing for colorectal cancer earlier," researcher Elizabeth Schaefer, an associate scientist of surveillance and health equity science with the ACS, said in a news release. The ACS lowered its recommended age to begin colon cancer screening from 50 to 45 in 2018, and the U.S. Preventive Services Task Force followed suit in 2021, researchers said in background notes. To see whether this made a difference, researchers analyzed surveillance data on colon cancer kept by the National Cancer Institute. Results show that colon cancer diagnoses accelerated to 12% per year in people 45 to 49 between 2019 and 2022, following the change in screening recommendations, one of the studies found. That's up from an average annual increase of 1% between 2004 to 2019 among that age group, researchers said. Similarly, there was an average annual increase under 2% for adults 20 to 39, 2% among those 40 to 44 and nearly 3% among those 50 to 54. The increase in colon cancer cases for the 45-to-49 group was driven by a steep rise in the detection of early-stage colon cancers, results show. Since the screening age was lowered, nearly 19% more localized colon cancers and 25% more localized rectal cancers were diagnosed each year in that age group, researchers said. These cancers have not had a chance to spread to other parts of the body and usually cause no symptoms. American Cancer Society researchers also found that colon cancer screening among adults 45 to 49 increased by 62% between 2019 and 2023, according to findings from the second study. In that study, researchers analyzed data on colon cancer screening gathered by the National Health Interview Survey, a regular poll taken by the U.S. Centers for Disease Control and Prevention. Results showed that stool-based colon cancer testing increased more than fivefold among 45- to 49-year-olds between 2019 and 2023, and colonoscopies increased by 43%. "It's not only thrilling to see the increase in colorectal cancer screening among younger adults, but also how it likely ties into rises in earlier stage diagnosis as noted in the other ACS-led paper," researcher Jessica Star said in a news release. She's an associate scientist of cancer risk factors and screening surveillance research at the American Cancer Society. Dr. David Rivadeneira, director of the Northwell Health Cancer Institute at Huntington Hospital on Long Island, N.Y., and a colorectal cancer specialist, agrees with the researchers' take on their data. "I think both studies basically show that the screening recommendations are having a significant positive impact, meaning it's doing what it's supposed to do," Rivadeneira, who was not involved in the research, said in a news release. "It's supposed to pick up early cancers, and that's one of the good things about these two studies, that it looks like the vast majority of these cancers are in early stage, which is good because early-stage colon cancer is extremely curative," he said. The recommendation to have a colonscopy at age 45 is affecting survival in these patients, he continued. "Imagine if these patients were not screened at 45 and they have a cancer at this age. They wait till 50. That's five years down the road," Rivadeneira said. "Many of these patients would have distant metastatic or far advanced cancer where the cure rates are not so good." The two new studies were published Aug. 4 in the Journal of the American Medical Association. More information The U.S. Centers for Disease Control and Prevention has more on colon cancer screening. Copyright © 2025 HealthDay. All rights reserved.
UPI
2 days ago
- UPI
Multiple sclerosis could affect health years before classic symptoms
New research from Canada's University of British Columbia found patients diagnosed with multiple sclerosis started to experience new health issues up to 15 years before showing the classic symptoms of the condition. Photo by Adobe Stock/HealthDay Aug. 4 (UPI) -- People with multiple sclerosis, or MS, begin experiencing new health issues up to 15 years before the classic signs of the illness appear, Canadian research shows. "MS can be difficult to recognize as many of the earliest signs -- like fatigue, headache, pain and mental health concerns -- can be quite general and easily mistaken for other conditions," study senior author Helen Tremlett noted. "Our findings dramatically shift the timeline for when these early warning signs are thought to begin, potentially opening the door to opportunities for earlier detection and intervention," said Tremlett, a professor of neurology at the University of British Columbia in Vancouver. Her team published its findings Friday in JAMA Network Open. MS is an autoimmune illness in which the body's immune system goes awry, attacking the protective myelin sheath that surrounds nerves within the brain and along the spinal cord. Communication breaks down between the brain and the body, leading to progressive disability. The new study that suggests MS may begin more than a decade before a clinical diagnosis. Tremlett's group combed through British Columbia health data for 12,000 people with or without MS. Records went back as far as 25 years prior to an MS patient's diagnosis. That's far longer than the five to 10 years covered in earlier studies looking at disease onset. The main findings: Fifteen years before the onset of classic MS symptoms, there was a noticeable uptick in patient visits to their general practitioner, or in visits to specialists for issues like fatigue, pain and dizziness, as well as mental health issues such as anxiety and depression. Twelve years before symptom onset, visits to psychiatrists began to rise. Eight to nine years before, visits to neurologists and eye specialists rose, perhaps linked to issues such as blurred vision or eye pain. Three to five years before, researchers noted a rise in visits to emergency departments and/or radiology facilities. One year before, visits peaked for a wide range of different physician types, such as neurologists, radiologists and emergency doctors. "These patterns suggest that MS has a long and complex prodromal phase -- where something is happening beneath the surface but hasn't yet declared itself as MS," said study first author Dr. Marta Ruiz-Algueró, a postdoctoral fellow at UBC. "We're only now starting to understand what these early warning signs are, with mental health-related issues appearing to be among the earliest indicators," she added in a news release. The researchers stressed that the early issues that drove MS patients to seek out care can be caused by a myriad of health conditions. Simply experiencing these conditions does not mean a person will go on to develop MS. Nevertheless, "By identifying these earlier red flags, we may eventually be able to intervene sooner -- whether that's through monitoring, support or preventive strategies," Tremlett said a university news release. "It opens new avenues for research into early biomarkers, lifestyle factors and other potential triggers that may be at play during this previously overlooked phase of the disease." More information Find out more about multiple sclerosis at the National Multiple Sclerosis Society Copyright © 2025 HealthDay. All rights reserved.
UPI
4 days ago
- UPI
Deaths among young people who inhale 'laughing gas' are soaring
Children and teenagers in the U.S. are increasingly inhaling nitrous oxide, or laughing gas, to get high -- and deaths linked to use of the legal inhalant have increased 578% in the last 13 years. Photo courtesy FDA/HealthDay News It's no laughing matter: Kids and teens across America are increasingly inhaling nitrous oxide, better known as "laughing gas," to get high. Too often, this ends in tragedy. U.S. deaths linked to misuse of the common, legal inhalant climbed nearly sevenfold -- 578% -- between 2010 and 2023, a new report finds. In 2023, 156 Americans, many of them children, died from huffing nitrous oxide, according to a new study. "This is not local to one area; it's everywhere," said study co-author Andrew Yockey, assistant professor of public health at the University of Mississippi. "And it absolutely deserves national surveillance," he added in a news release. "The numbers are still small right now, but they're growing and they're growing fast." There are no age restrictions on buying nitrous oxide, and it "is available online and in gas stations across the country, so, these products become an easy way to get high, and the companies know that," Yockey said. "How long do we have to wait before we consider this a problem?" he asked. His team published its findings July 30 in JAMA Network Open. Nitrous oxide, often referred to as "whippets," is usually sold in canisters and access appears to be growing. "From about 2020 on, you really started to see two things: nitrous oxide products appearing in gas stations, online, etc., and then in 2023, the U.K. banned nitrous oxide," Yockey said. "I think that's when some of those products started creeping in globally." He noted that many nitrous oxide products come in flavors that are especially enticing to kids: Berries or cotton candy, for example. Products often come with flavored nozzles. "These flavored nozzles -- bubblegum, mango -- tell me these aren't being marketed to kids?" Yockey said. Unsurprisingly, kids and teens are most prone to experimenting with nitrous oxide. In fact, eighth-graders make up a big proportion of users, the research showed. However, use comes with risks: Blood clots, frostbite, asphyxiation, heart palpitations, hallucinations and even paralysis, brain damage or death, according to the study authors. The research focused on 14 years of U.S. Centers for Disease Control and Prevention data on nitrous oxide-related deaths. Fatalities were rare and relatively stable until about 2010, when there were 23 deaths nationwide. But after that point, death rates began to climb. "What's especially concerning is how accessible and deceptively safe nitrous oxide seems," said study co-author Rachel Hoopsick, assistant professor of health and kinesiology at the University of Illinois at Urbana-Champaign. "It's legal, easy to buy and often viewed as harmless. But frequent or high-volume use can lead to serious neurological damage, psychiatric symptoms or even death." She said researchers are particularly worried about young people experimenting without understanding the risks. "The rise in harm calls for not only prevention," Hoopsick said in a news release, "But also stronger harm-reduction strategies." The U.S. Food and Drug Administration did issue a warning earlier this year, highlighting the dangers of inhaling nitrous oxide. That warning lists 15 nitrous oxide products, with names like Baking Bad, Cloud 9ine, Cosmic Gas and Whip-It!, but Yockey and Hoopsick are convinced there are dozens more. "We started researching nitrous oxide misuse after seeing headlines about young people dying from what many believed was a harmless substance," Hoopsick said. "Around the same time, we were both hearing anecdotal reports of nitrous oxide use among students on our respective campuses. These weren't just isolated incidents; they pointed to a larger, overlooked public health issue." Much more needs to be done to get the word out to parents and kids that "laughing gas" is far from harmless, the team said. "Public awareness is far behind where it needs to be," Hoopsick said. "Most people -- including parents, educators and even some health care providers -- don't realize how common nitrous oxide use has become or how dangerous it can be. "I want them to know that legal doesn't mean safe and that early, nonjudgmental conversations can make a real difference," she added. More information Find out more about the dangers of nitrous oxide at the Cleveland Clinic. Copyright © 2025 HealthDay. All rights reserved.
